ROIV Earnings

Quarterly EPS
$0.23
Q3 2025
$-0.29
Q4 2025
$-0.33
Q1 2026
$-0.17
Q2 2026
$-0.38
Q3 2026
$0.42
Q4 2026
$-0.26
Q1 2027
$-0.27
Q2 2027
Latest Revenue35.1M
Latest Net Income-137211000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2027-$0.2735.1M-137211000+2,135.6%-58.8%
Q1 2027-$0.261.4M-290606000-33.5%+21.2%
Q4 2026$0.422.5M355.7M-66.7%+244.8%
Q3 2026-$0.382.0M-313701000-77.8%-265.2%
Q2 2026-$0.171.6M-166039000-64.9%+45.2%
Q1 2026-$0.332.2M-273911000-72.8%-353.8%
Q4 2025-$0.297.6M-252375000-16.1%-52.6%
Q3 2025$0.239.0M118.1M-42.1%-96.4%
Q2 2025-$0.314.5M-279924000——
Q1 2025$0.138.0M57.5M——
Q4 2024-$0.199.0M-182496000——
Q3 2024$6.3715.6M5.1B——
Roivant Sciences Ltd. Common Shares (ROIV) — Earnings